Breaking News Bar

Business News and Information

Eli Lilly still confident in benefits of Covid antibody treatment despite end to hospital study

"It's disappointing, of course. We would have liked to have shown a benefit in the hospital," Eli Lilly CEO Dave Ricks told CNBC.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear